Microbiological Substitution of Drug Composition for the Treatment of Generalized Periodontitis in Patients with Diabetes Mellitus
DOI:
https://doi.org/10.33295/1992-576X-2025-3-36Keywords:
generalized periodontitis, diabetes mellitus, drug composition, microbiological studiesAbstract
Summary. Treatment of periodontal diseases in patients with diabetes mellitus is associated with specific difficulties. This is due to the problems with tissue regeneration and wound healing that these patients have. The use of newer drugs allows for the stimulation of these processes. A drug composition has been proposed for the treatment of generalized periodontitis in patients with diabetes mellitus. To substantiate its clinical use, microbiological studies were conducted to compare the antibacterial activity of several antibacterial drugs.
Aim: to determine the antibacterial activity of the proposed drug composition on various strains of microorganisms and mixed microflora of periodontal pockets of patients with diabetes mellitus.
Material and methods. For the microbiological study of medicinal products, a technique was used to measure the ability of medicines in a liquid state to penetrate the thickness of agar. This is the so-called agar diffusion method.
Results. Determination of antibacterial activity on test strains Staphylococcus aureus (ATCC 27923), Escherichia coli (ATCC 001048), and Candida albicans (ATCC 885663) showed sufficient antibacterial activity of the proposed drug composition. The obtained results of the antibacterial action of the studied drugs on the mixed microflora of periodontal pockets in patients with generalized periodontitis, on the background of diabetes mellitus, show that, according to the assessment of their antibacterial action, etonia, miramistin, and chlorgexidine have a moderate antibacterial effect. Metronidazole and the proposed drug composition have a pronounced antibacterial effect.
Conclusions. The obtained results of the antibacterial action of the studied drugs on the mixed microflora of periodontal pockets in patients with generalized periodontitis, on the background of diabetes mellitus, show that, according to the assessment of their antibacterial action, etonia, miramistin, and chlorgexidine have a moderate antibacterial effect. Metronidazole and the proposed drug composition have a pronounced antibacterial effect.
Downloads
References
Kinane, D.F., Stathopoulou, P.G., Papapanou, P.N. (2017). Periodontal diseases. Nature Reviews Disease Primers, 3: 1–14. DOI: https://doi.org/10.1038/nrdp.2017.38
Steele, J.G., Treasure, E.T., O’Sullivan, I., Morris, J., Murray, J.J. (2012). Adult dental health survey 2009: Transformations in British oral health 1968—2009. Br. Dent. J., 213(10): 523–527. DOI: https://doi.org/10.1038/sj.bdj.2012.1057
Dye, B.A. (2012). Global periodontal disease epidemiology. Periodontology 2000, 58(1): 10–25. DOI: https://doi.org/10.1111/j.1600-0757.2011.00413.x
Petersen, P.E., Ogawa, H. (2012). The global burden of periodontal disease: Towards integration with chronic disease prevention and control. Periodontology 2000, 60(1): 15–39. DOI: https://doi.org/10.1111/j.1600-0757.2011.00425.x
Ananieva, M.M., Faustova, M.O., Loban’, G.A., Chumak, Yu.V. (2022). Current approaches of EUCAST committee to determining susceptibility of odontogenic infections to antibiotics. Current problems of modern medicine, 22(77): 168–174. [ Ананьєва, М. М., Фаустова, М. О., Лобань, Г. А., Чумак Ю. В. (2022). Сучасні підходи комітету EUCAST до визначення чутливості збудників одонтогенних інфекцій до антибіотиків. Актуальні проблеми сучасної медицини, 22(77): 168–174]. DOI: https://doi.org/10.31718/2077-1096.22.1.168
Zachepylo, S.V. (2021). Assessment of the sensitivity of clinical strains of C. albicans isolated from patients with pharyngomycosis to the combined action of Monarda essential oil and antifungal drugs. Bulletin of Problems of Biology and Medicine, 1(159): 184–188. [ Зачепило, С. В. (2021). Оцінка чутливості клінічних штамів C. albicans, виділених від хворих на фарингомікоз, до комбінованої дії ефірної олії монарди та протигрибкових препаратів. Вісник проблем біології і медицини, 1(159): 184–188. ]. DOI: https://doi/org/10.29254/2077-4214-2021-1-159-184-188
EUCAST (European Committee on Antimicrobial Susceptibility Testing) Breakpoint tables for interpretation of MICs for antifungal agents. Version 10.0, valid from 2020-02-04. URL: https://www.eucast.org/astoffungi/clinicalbreakpointsforantifungals/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 “VYDAVNYCHYY BUDYNOK EXPERT” LLC
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
